PD
HAE icon

Point72 (DIFC)’s Haemonetics HAE Stock Holding History

Point72 (DIFC)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$174K Sell
3,572
-83,906
-96% -$5.19M 0.01% 472
2025
Q2 		$6.53M Buy
87,478
+87,236
+36,048% +$5.78M 0.25% 101
2025
Q1 		$15.4K Buy
+242
New +$16.5K ﹤0.01% 1397

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 (DIFC)'s HAE Position: Q3 2025 in Review

Point72 (DIFC) reduced its Haemonetics (HAE) stake by 96% in Q3 2025, selling an estimated $5.19M and leaving 3,572 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #472.

Point72 (DIFC) first reported a position in HAE in Q1 2025 and has held it in 3 quarters since. The position peaked at $6.53M in Q2 2025. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Point72 (DIFC) held 3,572 shares of Haemonetics worth $174K as of Q3 2025.
  • Point72 (DIFC) sold 83,906 Haemonetics shares in Q3 2025, an estimated $5.19M.
  • Haemonetics made up 0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #472 holding.
  • Point72 (DIFC) first reported a position in Haemonetics in Q1 2025 and has held it in 3 quarters since.
  • Point72 (DIFC)'s Haemonetics position peaked at $6.53M in Q2 2025.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.